Literature DB >> 3337116

IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?

B A Julian1, F B Waldo, A Rifai, J Mestecky.   

Abstract

Although its prevalence and clinical importance in the United States are stated to be low, we believe IgA nephropathy occurs as commonly in this country as in Western Europe. Initial reports suggested the disease was perhaps restricted to France and synonymous with "benign recurrent hematuria," but longer follow-up has proven both conclusions incorrect. Obviously, major gaps persist in our understanding of the immunopathogenesis and the natural history. The latency of the American investigative response calls for more intensive clinical and laboratory studies of the most common primary glomerulonephritis worldwide.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337116     DOI: 10.1016/0002-9343(88)90019-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  61 in total

1.  Analysis of an expanded width of albumin fraction by cellulose acetate membrane electrophoresis in IgA nephropathy urine before treatment.

Authors:  Ryoko Machii; Kazuyuki Matsuda; Nobuo Hiratsuka; Kayo Sugimoto; Osamu Hotta; Yoshihisa Itoh; Hiroshi Yoshida; Kiyoko Shiba
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

2.  [Leukocytoclastic vasculitis].

Authors:  C Sunderkötter; J Roth; G Bonsmann
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

3.  Detecting bladder cancer.

Authors:  A Schattner
Journal:  BMJ       Date:  1990-12-01

Review 4.  Corticosteroid therapy in IgA nephropathy.

Authors:  Jicheng Lv; Damin Xu; Vlado Perkovic; Xinxin Ma; David W Johnson; Mark Woodward; Adeera Levin; Hong Zhang; Haiyan Wang
Journal:  J Am Soc Nephrol       Date:  2012-04-26       Impact factor: 10.121

5.  Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.

Authors:  Jennifer S Moore; Rose Kulhavy; Milan Tomana; Zina Moldoveanu; Hitoshi Suzuki; Rhubell Brown; Stacy Hall; Mogens Kilian; Knud Poulsen; Jiri Mestecky; Bruce A Julian; Jan Novak
Journal:  Mol Immunol       Date:  2007-02-02       Impact factor: 4.407

6.  Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy.

Authors:  Grazia Serino; Fabio Sallustio; Sharon N Cox; Francesco Pesce; Francesco P Schena
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

7.  T-cell epitopes recognized within the 65,000 MW hsp in patients with IgA nephropathy.

Authors:  K Warr; F Fortune; S Namie; A Wilson; T Shinnick; R Van der Zee; G Williams; T Lehner
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

8.  Oxford classification of IgA nephropathy: Broadening the scope of the classification.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2012-04-05

9.  Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients.

Authors:  Taro Misaki; Shuhei Naka; Keiko Kuroda; Ryota Nomura; Tempei Shiooka; Yoshitaka Naito; Yumiko Suzuki; Hideo Yasuda; Taisuke Isozaki; Kazuhiko Nakano
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

10.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.

Authors:  H Yoshida; T Mitarai; T Kawamura; T Kitajima; Y Miyazaki; R Nagasawa; Y Kawaguchi; H Kubo; I Ichikawa; O Sakai
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.